The need for effective adjuvant therapies and evidence that the immune system plays a prominent role in the development and progression of melanoma (Curiel-Lewandrowski & Demierre, 2000) have led to ...
Chimeric antigen receptor (CAR) therapies utilize engineered receptors that are able to redirect immune cells to identify and destroy cancer cells that express a specific antigen. At present, CAR-T ...